-transparent.png){kind=logo}
In experiments of curative vaccination, carried out with the use of an experimental model similar to the current practice of treatment with antirabies preparations, the advantages of using tissue-culture rabies vaccine with immunogenic potency equal to 1.3 international units (I. U.) were shown. In these experiments the vaccine was introduced into guinea pigs infected with fixed rabies virus, the course of vaccination consisting of 14 daily injections. No correlation between the induction of virus-neutralizing antibodies and the immunogenic potency of tissue-culture rabies vaccine was established: the use of the vaccine with immunogenic potency equal to 0,3 and 1,3 I.U. had no essential influence on the level of antibody formation in the animals.
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 1959,
American journal of veterinary research,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 1969,
Archiv fur experimentelle Veterinarmedizin,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 1988,
Annali dell'Istituto superiore di sanita,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 1981,
Archives roumaines de pathologie experimentales et de microbiologie,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 1967,
Bulletin de l'Academie nationale de medecine,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 2006,
Voprosy virusologii,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
January 1967,
Bulletin - Office international des epizooties,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
December 1970,
Archivio veterinario italiano,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
July 1960,
The Journal of the Indiana State Medical Association,
A A Movsesiants, and
L N Romanova, and
E M Tsetlin, and
R Ia Shkol'nik, and
P V Kolotvina, and
S V Gribencha, and
I F Barinskiĭ, and
V V Kasatkin, and
A A Sumarokov
August 1998,
Vaccine,
